In a move heralded by President Donald Trump as a monumental victory for American consumers, pharmaceutical giant Pfizer has agreed to a deal that promises to slash the prices of some of its drugs. However, the market’s reaction has told a very different story. This reaction raises questions about the actual impact of the agreement on the firm’s bottom line…
Tag: Pfizer
-
RSV Infant Vaccine: Latest Developments in South Africa
A groundbreaking vaccine to protect infants from severe respiratory syncytial virus (RSV) is now available in South Africa’s private healthcare sector. Still, a decision on its inclusion in the public programme remains pending. The country’s National Advisory Group on Immunisation (NAGI) has formally recommended the RSV infant vaccine for all pregnant women. They have left the final decision to the…
-
Are New Cancer Treatments Worth the Price?
A significant number of cancer drugs approved since 2000, as reviewed by Bloomberg News, have never been definitively shown to extend patient survival for their approved uses. This raises questions about the growing cost of cancer treatments. The landscape of cancer treatment has been revolutionized over the past three decades, with over 200 new cancer drugs greenlit by the US…